120 related articles for article (PubMed ID: 9021661)
1. [A 26-week oral repeated dose toxicity study of a new antineoplastic agent S-1 in rats].
Hakoi K; Hayashi T; Ohmae S; Besshi K
J Toxicol Sci; 1996 Nov; 21 Suppl 3():545-60. PubMed ID: 9021661
[TBL] [Abstract][Full Text] [Related]
2. [A 13-week oral repeated dose toxicity study of a new antineoplastic agent S-1 in rats].
Hayashi T; Hasegawa H; Tanaka G; Ohmae S
J Toxicol Sci; 1996 Nov; 21 Suppl 3():505-26. PubMed ID: 9021659
[TBL] [Abstract][Full Text] [Related]
3. [An oral repeated dose toxicity study of a new antineoplastic agent S-1 in dogs. I. A 13-week repeated dose toxicity study. II. An ophthalmologic toxicity recovery study].
Hayashi T; Yamaguchi S; Kito S; Tanaka G; Kurokawa K; Hirota T
J Toxicol Sci; 1996 Nov; 21 Suppl 3():527-44. PubMed ID: 9021660
[TBL] [Abstract][Full Text] [Related]
4. [A 52-week oral toxicity study of a new antineoplastic agent S-1 in dogs].
Kitajima S; Okamura T; Kobayashi K; Watari N; Inoue H; Enomoto M; Yamaguchi S
J Toxicol Sci; 1996 Nov; 21 Suppl 3():561-88. PubMed ID: 9021662
[TBL] [Abstract][Full Text] [Related]
5. [Oral single-dose toxicity study of a new antineoplastic agent S-1, and its components, CDHP, and Oxo].
Hayashi T; Tanaka G; Irimura K; Hirota T; Ohmae S
J Toxicol Sci; 1996 Nov; 21 Suppl 3():495-504. PubMed ID: 9021658
[TBL] [Abstract][Full Text] [Related]
6. [Reproductive and developmental toxicity study of a new antineoplastic agent, S-1 (I)--Fertility study in rats by oral administration].
Shinomiya M; Imamura K; Izumi K
J Toxicol Sci; 1996 Nov; 21 Suppl 3():589-602. PubMed ID: 9021663
[TBL] [Abstract][Full Text] [Related]
7. [Reproductive and developmental toxicity study of a new antineoplastic agent, S-1 (IV)--Perinatal and postnatal study in rats by oral administration].
Furuhashi T; Kato M; Fujimura T; Koida M
J Toxicol Sci; 1996 Nov; 21 Suppl 3():643-59. PubMed ID: 9021666
[TBL] [Abstract][Full Text] [Related]
8. [Reproductive and developmental toxicity study of a new antineoplastic agent, S-1 (III)--Teratological study in rabbits by oral administration].
Shinomiya M; Yukiyama S; Ikebuchi K
J Toxicol Sci; 1996 Nov; 21 Suppl 3():619-41. PubMed ID: 9021665
[TBL] [Abstract][Full Text] [Related]
9. [Reproductive and developmental toxicity study of a new antineoplastic agent, S-1 (II)--Teratological study in rats by oral administration].
Yukiyama S; Shinomiya M; Ikebuchi K; Sato T
J Toxicol Sci; 1996 Nov; 21 Suppl 3():603-18. PubMed ID: 9021664
[TBL] [Abstract][Full Text] [Related]
10. [Immunotoxic effects of a new antineoplastic agent S-1 in mice--comparison with S-1, UFT and 5-FU].
Kouchi Y; Maeda Y; Morinaga H; Ohuchida A
J Toxicol Sci; 1996 Nov; 21 Suppl 3():691-701. PubMed ID: 9021669
[TBL] [Abstract][Full Text] [Related]
11. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
12. [Mutagenicity study of a new antineoplastic agent S-1, and its components, CDHP, and Oxo].
Ohuchida A; Kouchi Y; Sato S; Maeda Y
J Toxicol Sci; 1996 Nov; 21 Suppl 3():675-89. PubMed ID: 9021668
[TBL] [Abstract][Full Text] [Related]
13. [Antigenicity tests of a new antineoplastic agent S-1].
Maeda Y; Morinaga H; Izumi K; Ikebuchi K; Kouchi Y
J Toxicol Sci; 1996 Nov; 21 Suppl 3():661-73. PubMed ID: 9021667
[TBL] [Abstract][Full Text] [Related]
14. Increased intestinal permeability correlates with gastrointestinal toxicity among formulations of the fluorouracil analogue tegafur in rats.
Korenaga D; Honda M; Yasuda M; Inutsuka S; Nozoe T; Tashiro H
Eur Surg Res; 2002; 34(5):351-6. PubMed ID: 12364819
[TBL] [Abstract][Full Text] [Related]
15. NTP Toxicology and Carcinogenesis Studies of 1,4-Dichlorobenzene (CAS No. 106-46-7) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1987 Jan; 319():1-198. PubMed ID: 12748734
[TBL] [Abstract][Full Text] [Related]
16. Toxicology and carcinogenesis studies of N,N-dimethyl-p-toluidine (CAS No. 99-97-8) in F344/N rats and B6C3F1/N mice (gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2012 Sep; (579):1-211. PubMed ID: 23027199
[TBL] [Abstract][Full Text] [Related]
17. Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1 M tegafur-0.4 M gimestat-1 M otastat potassium) in advanced gastric cancer patients.
Sakata Y; Ohtsu A; Horikoshi N; Sugimachi K; Mitachi Y; Taguchi T
Eur J Cancer; 1998 Oct; 34(11):1715-20. PubMed ID: 9893658
[TBL] [Abstract][Full Text] [Related]
18. NTP Toxicology and Carcinogenesis Studies of p-Nitrobenzoic Acid (CAS No. 62-23-7) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Dec; 442():1-306. PubMed ID: 12595921
[TBL] [Abstract][Full Text] [Related]
19. Diamine oxidase, a plasma biomarker in rats to GI tract toxicity of oral fluorouracil anti-cancer drugs.
Moriyama K; Kouchi Y; Morinaga H; Irimura K; Hayashi T; Ohuchida A; Goto T; Yoshizawa Y
Toxicology; 2006 Jan; 217(2-3):233-9. PubMed ID: 16278042
[TBL] [Abstract][Full Text] [Related]
20. [New oral anticancer drug, TS-1 (S-1)--from bench to clinic].
Shirasaka T; Tsukuda M; Inuyama Y; Taguchi T
Gan To Kagaku Ryoho; 2001 Jun; 28(6):855-64. PubMed ID: 11432358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]